Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Acumen Pharmaceuticals (ABOS) vs. Competitors

719 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
ABOSAcumen Pharmaceuticals$0.21$16.64M-0.14-88.18%HoldUnlock the ABOS analyst price target with TipRanks PremiumABOSUnlock the ABOS top-analyst price target with TipRanks Premium
VTGNVistaGen Therapeutics$0.18$8.33M-0.10-95.26%HoldUnlock the VTGN analyst price target with TipRanks PremiumABOS vs VTGNUnlock the VTGN top-analyst price target with TipRanks Premium
IKTInhibikase Therapeutics$1.52$228.64M-3.40-5.00%Strong BuyUnlock the IKT analyst price target with TipRanks PremiumABOS vs IKTUnlock the IKT top-analyst price target with TipRanks Premium
SRZNSurrozen$31.61$607.69M-0.72160.81%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumABOS vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
TCRXTScan Therapeutics$0.16$12.58M-0.19-85.84%HoldUnlock the TCRX analyst price target with TipRanks PremiumABOS vs TCRXUnlock the TCRX top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
ABOSAcumen Pharmaceuticals0.21-1.52-87.63%
VTGNVistaGen Therapeutics0.18-3.62-95.26%
IKTInhibikase Therapeutics1.52-0.01-0.65%
SRZNSurrozen31.6118.63143.53%
TCRXTScan Therapeutics0.16-0.94-85.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts